Identification of Gene Markers Associated with COVID-19 Severity and Recovery in Different Immune Cell Subtypes

被引:5
作者
Ren, Jing-Xin [1 ]
Gao, Qian [2 ]
Zhou, Xiao-Chao [3 ]
Chen, Lei [4 ]
Guo, Wei [5 ,6 ]
Feng, Kai-Yan [7 ]
Lu, Lin [8 ]
Huang, Tao [9 ,10 ]
Cai, Yu-Dong [1 ]
机构
[1] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China
[2] Shanghai Jiao Tong Univ, Shanghai Childrens Med Ctr, Sch Med, Dept Pharm, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ Sch Med SJTUSM, Ctr Single Cell Om, Sch Publ Hlth, Shanghai 200025, Peoples R China
[4] Shanghai Maritime Univ, Coll Informat Engn, Shanghai 201306, Peoples R China
[5] Shanghai Jiao Tong Univ Sch Med SJTUSM, Key Lab Stem Cell Biol, Shanghai 200030, Peoples R China
[6] Chinese Acad Sci, Shanghai Inst Biol Sci SIBS, Shanghai 200030, Peoples R China
[7] Guangdong AIB Polytech Coll, Dept Comp Sci, Guangzhou 510507, Peoples R China
[8] Columbia Univ, Med Ctr, Dept Radiol, New York, NY 10032 USA
[9] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, Biomed Big Data Ctr,CAS Key Lab Computat Biol, Shanghai 200031, Peoples R China
[10] Univ Chinese Acad Sci, Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China
来源
BIOLOGY-BASEL | 2023年 / 12卷 / 07期
关键词
immune cell; COVID-19; severity; machine learning;
D O I
10.3390/biology12070947
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Simple Summary It is known that COVID-19 causes dynamic changes in the immune system. At different stages of the course of COVID-19, the immune cells may exhibit different patterns, which have not been fully uncovered. In this study, a machine-learning-based method was designed to deeply analyze the scRNA-seq data of three types of immune cells from patients with COVID-19, including B cells, T cells, and myeloid cells. Four levels of COVID-19 severity/outcome were involved for each cell type. As a result, several essential genes were obtained, and some of them could be confirmed to be related to SARS-CoV-2 infection. As COVID-19 develops, dynamic changes occur in the patient's immune system. Changes in molecular levels in different immune cells can reflect the course of COVID-19. This study aims to uncover the molecular characteristics of different immune cell subpopulations at different stages of COVID-19. We designed a machine learning workflow to analyze scRNA-seq data of three immune cell types (B, T, and myeloid cells) in four levels of COVID-19 severity/outcome. The datasets for three cell types included 403,700 B-cell, 634,595 T-cell, and 346,547 myeloid cell samples. Each cell subtype was divided into four groups, control, convalescence, progression mild/moderate, and progression severe/critical, and each immune cell contained 27,943 gene features. A feature analysis procedure was applied to the data of each cell type. Irrelevant features were first excluded according to their relevance to the target variable measured by mutual information. Then, four ranking algorithms (last absolute shrinkage and selection operator, light gradient boosting machine, Monte Carlo feature selection, and max-relevance and min-redundancy) were adopted to analyze the remaining features, resulting in four feature lists. These lists were fed into the incremental feature selection, incorporating three classification algorithms (decision tree, k-nearest neighbor, and random forest) to extract key gene features and construct classifiers with superior performance. The results confirmed that genes such as PFN1, RPS26, and FTH1 played important roles in SARS-CoV-2 infection. These findings provide a useful reference for the understanding of the ongoing effect of COVID-19 development on the immune system.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Plasma Oxylipins and Their Precursors Are Strongly Associated with COVID-19 Severity and with Immune Response Markers
    Karu, Naama
    Kindt, Alida
    Lamont, Lieke
    van Gammeren, Adriaan J.
    Ermens, Anton A. M.
    Harms, Amy C.
    Portengen, Lutzen
    Vermeulen, Roel C. H.
    Dik, Willem A.
    Langerak, Anton W.
    van der Velden, Vincent H. J.
    Hankemeier, Thomas
    METABOLITES, 2022, 12 (07)
  • [2] Markers Associated with COVID-19 Susceptibility, Resistance, and Severity
    Fakhroo, Aisha D.
    Al Thani, Asmaa A.
    Yassine, Hadi M.
    VIRUSES-BASEL, 2021, 13 (01):
  • [3] Exploring immune response and lab markers across COVID-19 severity levels
    Desheva, Y.
    Shvedova, T.
    Lerner, A.
    Kudar, P.
    Kopteva, O.
    Petrachkova, D.
    Koroleva, I.
    Leontieva, G.
    Ponkratov, S.
    Suvorov, A.
    AIMS ALLERGY AND IMMUNOLOGY, 2024, 8 (04): : 216 - 231
  • [4] Metabolic and Immune Markers for Precise Monitoring of COVID-19 Severity and Treatment
    Rendeiro, Andre F.
    Vorkas, Charles Kyriakos
    Krumsiek, Jan
    Singh, Harjot K.
    Kapadia, Shashi N.
    Cappelli, Luca Vincenzo
    Cacciapuoti, Maria Teresa
    Inghirami, Giorgio
    Elemento, Olivier
    Salvatore, Mirella
    FRONTIERS IN IMMUNOLOGY, 2022, 12
  • [5] Identification of Whole-Blood DNA Methylation Signatures and Rules Associated with COVID-19 Severity
    Yuan, Fei
    Ren, JingXin
    Liao, HuiPing
    Guo, Wei
    Chen, Lei
    Feng, KaiYan
    Huang, Tao
    Cai, Yu-Dong
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2023, 28 (11):
  • [6] Identification of Distinct Immune Cell Subsets Associated With Asymptomatic Infection, Disease Severity, and Viral Persistence in COVID-19 Patients
    Wang, Xiaorui
    Bai, Han
    Ma, Junpeng
    Qin, Hongyu
    Zeng, Qiqi
    Hu, Fang
    Jiang, Tingting
    Mao, Weikang
    Zhao, Yang
    Chen, Xiaobei
    Qi, Xin
    Li, Mengyang
    Xu, Jiao
    Hao, Jingcan
    Wang, Yankui
    Ding, Xi
    Liu, Yuanrui
    Huang, Tianlong
    Fang, Chao
    Ge, Changli
    Li, Dong
    Hu, Ke
    Ren, Xianwen
    Zhang, Baojun
    Zhang, Binghong
    Shi, Bingyin
    Zhang, Chengsheng
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [7] Exploring inflammatory markers of COVID-19 severity in Moroccans
    Bourhanbour, Asmaa Drissi
    Kattra, Aziza Bachir
    Aissaoui, Ouissal
    Ouair, Hind
    Benzekri, Driss
    Kholaiq, Halima
    Charra, Boubaker
    Jalila, El Bakkouri
    Bousfiha, Ahmed Aziz
    SCIENTIFIC AFRICAN, 2024, 24
  • [8] Association of biochemical markers with COVID-19 severity in Pakistan
    Iqbal, Rashid
    Niazi, Muhammad Aamir Khan
    Shabbir, Muhammad Usman
    Raza, Umama
    Saleem, Alina
    Bhatti, Theophilus
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2023, 73 (07) : 1403 - 1407
  • [9] The dynamics of immune response in COVID-19 patients with different illness severity
    Zhang, Bo
    Yue, Daoyuan
    Wang, Yun
    Wang, Feng
    Wu, Shiji
    Hou, Hongyan
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (02) : 1070 - 1077
  • [10] Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection
    Kovarik, Johannes J.
    Kaempf, Anna K.
    Gasser, Fabian
    Herdina, Anna N.
    Breuer, Monika
    Kaltenecker, Christopher C.
    Wahrmann, Markus
    Haindl, Susanne
    Mayer, Florian
    Traby, Ludwig
    Touzeau-Roemer, Veronique
    Grabmeier-Pfistershammer, Katharina
    Kussmann, Manuel
    Robak, Oliver
    Willschke, Harald
    Ay, Care
    Saeemann, Marcus D.
    Schmetterer, Klaus G.
    Strassl, Robert
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11